Cambridge Investment Research Advisors, Inc. Veru Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Veru Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 1,423,288 shares of VERU stock, worth $697,411. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,423,288
Previous 1,216,674
16.98%
Holding current value
$697,411
Previous $791,000
11.76%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VERU
# of Institutions
145Shares Held
46.3MCall Options Held
170KPut Options Held
2.25M-
Black Rock Inc. New York, NY7.65MShares$3.75 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA6.59MShares$3.23 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.25MShares$3.06 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.03MShares$1.49 Million0.0% of portfolio
-
State Street Corp Boston, MA2.23MShares$1.09 Million0.0% of portfolio
About VERU INC.
- Ticker VERU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,146,704
- Market Cap $39.3M
- Description
- Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....